参考文献/References:
[1]TORRE L A, BRAY F, SIEGEL R L, et al. Global cancer statistics, 2012 [J]. CA-A Cancer Journal for Clinicians, 2015, 65(2): 87-108.
[2]蒋雪梅(综述),李华,顿耀艳(审校).宫颈癌的研究新进展 [J]现代医药卫生,2015,31(21):3251-3253
[3]SASLOW D, SOLOMON D, LAWSON H W, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer [J]. Journal of Lower Genital Tract Disease, 2012, 16(3): 175-204.
[4]杨雪霞,刘健,黄春丽HPV-DNA的检测与分型诊断在宫颈癌筛查中的意义 [J]深圳中西医结合杂志,2016,26(9):58-59
[5]王霞,李霞斌,李宗恒HPV 16/18在宫颈上皮内瘤变及宫颈癌中表达 [J]中国病原生物学杂志,2017,12(2):182-184, 188
[6]刘玉萍,沈太敏,帅平,等成都市健康体检妇女人乳头状瘤病毒感染及基因亚型分析 [J]实用医院临床杂志,2015,12(6):52-54
[7]李世宁,阮思蓓,邓正华,等泸州地区人乳头瘤病毒感染的分子流行病学研究 [J]现代预防医学,2013,40(22):4109-4112
[8]邓健康,郭晓兰四川东北地区女性人乳头瘤病毒感染的型别分布 [J]国际检验医学杂志,2014,35(4):421-423
[9]Clifford GM,Swith JS,Plummer M,et al.Human papilloma virus types in invasive cervical cancer worldwide:a meta-analysis [J].Br J Cancer,2003,88(1):63-73
[10]姚军,李曼,钟萍,等HPV亚型感染的地域分布与宫颈病变的关系 [J]实用妇产科杂志,2011,27(1):34-38
[11]LO K W, WONG Y F, CHAN M K, et al. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China [J]. International Journal of Cancer,2002, 100(3): 327-331.
[12]曾莉,郭遂群,云径平,等广州地区宫颈癌组织标本中HPV感染情况的初步分析 [J]南方医科大学学报,2007,27(3):399-400
[13]杜宏,索兰草,刘红贤,等甘肃地区女性宫颈 HPV 感染的现状研究 [J]暨南大学学报(自然科学与医学版),2015,36(1):40-45
[14]肖林林,赵卫卫,彭攸,等区域内HPV亚型分布特点及其与宫颈病变的关系 [J]国际检验医学杂志,2017,38(3):360-362, 365
[15]Baseman JG,Koutsky LA.The epidemiology of human papillomavirus infections [J].J Clin Virol,2005,32(3):S 16-S 24
[16]SELLORS J W, MAHONY J B, KACZOROWSKI J, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada [J]. Canadian Medical Association Journal, 2000, 163(5): 503-508.
相似文献/References:
[1]梅丽,李丽,刘婷婷,等.高危型HPV病毒负荷量指导CINⅠ的治疗分析[J].中国计划生育和妇产科,2013,(03):0.
MEI Li,LI Li *,LIU Ting - ting.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(8):0.
[2]杨娟,关婷,蔡虹,等.高危型人乳头瘤病毒检测作为宫颈癌初筛手段的应用研究[J].中国计划生育和妇产科,2016,(02):0.
YANG Juan,GUAN Ting,CAI Hong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(8):0.
[3]黄晨玲子,罗新.清除下生殖道高危型人乳头瘤病毒感染的可行性与必要性[J].中国计划生育和妇产科,2016,(09):0.
Huang Chen-lingzi,Luo Xin,[J].Chinese Journal of Family Planning & Gynecotokology,2016,(8):0.
[4]徐惠琴.248例宫颈上皮内瘤变患者宫颈环形电切术后复发的相关危险因素分析[J].中国计划生育和妇产科,2016,(11):0.
XU Hui-qin,[J].Chinese Journal of Family Planning & Gynecotokology,2016,(8):0.
[5]王丽君,张锦文*,成建,等.235例细胞学阴性/高危型人乳头瘤病毒阳性患者宫颈病理结果分析[J].中国计划生育和妇产科,2017,(1):59.
WANG Li-jun,ZHANG Jin-wen*,CHENG Jian,et al.Analysis of cervical pathology in 235 cytology-negative/HR - HPV positive patients[J].Chinese Journal of Family Planning & Gynecotokology,2017,(8):59.
[6]李晓林,李婧,陈龙,等.高危型人乳头瘤病毒E 6/E 7 mRNA检测在意义不明的非典型鳞状上皮细胞中的分流价值[J].中国计划生育和妇产科,2017,(2):55.
LI Xiao-lin,LI Jing,CHEN Long,et al.Value of high-risk human papillomavirus E6 / E7 mRNA in atypical squamous cells of undetermined significance triage[J].Chinese Journal of Family Planning & Gynecotokology,2017,(8):55.
[7]李瑞琼,王晓银*.干扰素栓联合中药阴道灌洗治疗宫颈高危型人乳头瘤病毒感染疗效分析[J].中国计划生育和妇产科,2018,(5):38.
LI Rui-qiong,WANG Xiao-yin*.Efficacy of interferon suppository combined with traditional Chinese medicine vaginal lavage in treating cervical high-risk human papilloma virus infection[J].Chinese Journal of Family Planning & Gynecotokology,2018,(8):38.
[8]蔡蕊.高危型人乳头瘤病毒感染与宫颈炎、宫颈癌及
癌前病变的关系研究[J].中国计划生育和妇产科,2019,(4):86.
CAI Rui.Relationship between high-risk human papillomavirus infection and cervicitis, cervical cancer and precancerous lesions[J].Chinese Journal of Family Planning & Gynecotokology,2019,(8):86.